Short answer · Medically reviewed summary · Last updated: 2026-04-07
Hyper IgE Syndrome, also historically known as Job’s Syndrome, was first formally described in the medical literature in 1966 by Davis, Schaller, and Wedgwood, who observed two young girls with recurrent staphylococcal abscesses and cold skin infections. The Evolution of Discovery The name "Job’s Syndrome" was coined in reference to the biblical figure Job, who was "smitten with sore boils from the sole of his foot unto his crown." Initially, clinical understanding was limited to observing these recurring "cold" abscesses—so called because they lacked the typical warmth and redness of common inflammatory infections. For decades, researchers struggled to understand the underlying immunodeficiency, often misclassifying the condition as a generic phagocyte defect. Genetic Breakthroughs The landscape of Hyper IgE Syndrome shifted dramatically in 2007, when researchers identified mutations in the STAT3 gene as the primary cause of the autosomal dominant form.
What is the history of Hyper IgE Syndrome?
History of Hyper IgE Syndrome: when and how it was discovered, and the milestones in research since, medically reviewed.
Hyper IgE Syndrome, also historically known as Job’s Syndrome, was first formally described in the medical literature in 1966 by Davis, Schaller, and Wedgwood, who observed two young girls with recurrent staphylococcal abscesses and cold skin infections.
The Evolution of Discovery
The name "Job’s Syndrome" was coined in reference to the biblical figure Job, who was "smitten with sore boils from the sole of his foot unto his crown." Initially, clinical understanding was limited to observing these recurring "cold" abscesses—so called because they lacked the typical warmth and redness of common inflammatory infections. For decades, researchers struggled to understand the underlying immunodeficiency, often misclassifying the condition as a generic phagocyte defect.
Genetic Breakthroughs
The landscape of Hyper IgE Syndrome shifted dramatically in 2007, when researchers identified mutations in the STAT3 gene as the primary cause of the autosomal dominant form. This discovery allowed medical professionals to distinguish between different genetic subtypes, moving the field away from purely symptomatic diagnosis toward molecular precision. Modern technology has since revealed that Hyper IgE Syndrome is not just an infection-prone state, but a complex multisystem disorder affecting connective tissue, skeletal development, and vascular health.
From Misconception to Advocacy
Historically, the high levels of IgE in the blood led many to incorrectly categorize Hyper IgE Syndrome primarily as an allergic or atopic condition. We now know that while elevated IgE is a hallmark, it is a secondary marker of the underlying immune dysregulation. Over the last twenty years, patient advocacy groups have been instrumental in shifting the focus from managing acute skin infections to addressing the long-term pulmonary and skeletal needs of those living with Hyper IgE Syndrome. Today, clinical management emphasizes prophylactic antibiotics and specialized dermatological care, a far cry from the reactive treatments of the 1960s.
Disclaimer: This information is for educational purposes and should not be considered medical advice. Please consult with your primary care physician or an immunologist for diagnosis and treatment plans specific to your health history.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Online Mendelian Inheritance in Man (OMIM) entry for Hyper-IgE Syndrome
- Orphanet: Portal for rare diseases and orphan drugs
